BeStock  
Stocks › BRVE

Braveheart Bio BRVE

US equityMarket cap rank #2809Biotechnology
$21.35 +$0.08 (+0.38%)
Market closed · Oct 6, 5:40 am ET · Last extended-hours $21.35 0.00%
Open$21.57
Prev close$21.27
Day range$19.83 – $22.02
Volume889.0K
Market cap$1.92B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership68.9%+65.91 pts vs. prior quarter
Institutions holding8+7 vs. prior quarter
Insider trades (recent)22 buys / 0 sellsNet buying
Short interest2.73% of floatDays to cover 7.5 · as of 15 Sep 2026
Short-sale volume share20.8%5-day average of daily volume

Short-sale volume as % of daily volume

16%21%27%32%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$928.3K (5 inflow days, 15 outflow days).

The five largest holders on file together own 72.8% of shares outstanding.

Largest holders

  • Forbion Capital Partners B.V.26.47%
  • OrbiMed Advisors LLC14.77%
  • Andreessen Horowitz LLC12.41%
  • Travis Murdoch10.11%
  • Jiangsu Hengrui Pharmaceuticals Co.,Ltd9.00%
  • Frazier Life Sciences Management, LP6.19%
  • Jason Coloma1.71%
  • David Malek1.23%

By investor type

  • VC/PE Fund59.85%
  • Individual/Insider15.11%
  • Public Company9.00%
  • Mutual Fund0.08%

Reported short interest has risen from 1.20% to 2.73% of float over the last 3 biweekly reports (14 Aug 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 2,461,086 2.7% 7.5
31 Aug 2026 1,397,189 2.0% 5.6
14 Aug 2026 847,773 1.2% 1.3

Discussion

No comments yet — be the first to weigh in on BRVE.

Leave a comment

Scroll to Top